M. Sendur
发表
B. Yalcin,
B. Bilgin,
M. Hızal,
2017,
Future oncology.
Do tyrosine kinase inhibitors lose favor in treatment of first-line metastatic renal cell carcinoma?
B. Yalcin,
B. Bilgin,
M. Hızal,
2019,
Future oncology.
Burak Bilgin,
B. Yalcin,
B. Bilgin,
2017,
Current medical research and opinion.
B. Yalcin,
B. Bilgin,
M. Hızal,
2017,
Future oncology.
O. Erel,
S. Neşelioğlu,
Ö. Erel,
2019,
Journal of Oncological Sciences.
N. Zengi̇n,
A. Ulaş,
B. Yalcin,
2017,
Future oncology.
B. Yalcin,
B. Bilgin,
D. Şener Dede,
2017,
Current medical research and opinion.
B. Yalcin,
B. Bilgin,
Mehmet A N Şendur,
2019,
Expert opinion on biological therapy.
B. Yalcin,
B. Bilgin,
M. Hızal,
2019,
Future oncology.
S. Kahraman,
E. Algın,
Öznur Bal,
2022,
Acta Oncologica Turcica.
B. Yalcin,
B. Bilgin,
N. Özdemir,
2017,
Future oncology.
K. Altundag,
Y. Ozisik,
O. Yazıcı,
2015,
Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
B. Yalcin,
Mehmet A. N. Sendur,
M. Akıncı,
2014,
The New England journal of medicine.
N. Zengi̇n,
A. Ulaş,
B. Yalcin,
2015,
Future oncology.
B. Yalcin,
B. Bilgin,
M. Hızal,
2020,
Current medical research and opinion.
U. Demirci,
Sertaç Ak,
N. Karadurmuş,
2023,
Future oncology.
T. Erbas,
C. Sokmensuer,
B. Erbaş,
2014,
Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
N. Zengi̇n,
A. Ulaş,
B. Yalcin,
2015,
Future oncology.
U. Demirci,
B. Yalcin,
I. Çiçin,
2020,
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.